米国の法医学ゲノミクス市場規模、シェア、動向分析レポート：製品別、手法別、用途別、セグメント別予測、2025年～2033年

米国の法医学ゲノミクス市場規模・動向

米国の法医学ゲノミクス市場規模は2024年に2億5,650万米ドルと推定され、2033年には9億4,100万米ドルに達すると予測され、2025～2033年のCAGRは15.65%で拡大します。

この成長の原動力は、ゲノム技術の進歩、犯罪捜査における法医学DNA分析の採用増加、法医学研究とインフラに対する政府資金の増加です。さらに、法執行や法的手続きにおける正確かつ迅速な同定方法に対するニーズの高まりが、予測期間を通じて市場拡大の原動力となると考えられます。

犯罪率の上昇と捜査の複雑化

犯罪行為、特に暴力犯罪、性的暴行、殺人の発生率の増加は、法医学ゲノミクス市場の成長を促す主要因の1つです。刑事事件の量と複雑さが増すにつれて、正確で信頼できる証拠を提供する先進的ツールの必要性が高まっています。法医学ゲノミクスは、法執行機関が生物学的サンプルを非常に詳細な遺伝子レベルで分析することを可能にし、従来型法医学的手法と比較して、容疑者の特定や被害者のプロファイリングにおいて優れた精度を記載しています。

さらに、未解決事件や迷宮入り事件の増加に伴い、法執行機関は最新のゲノム技術を用いて保管されている証拠を再調査し、画期的な発見や事件解決につなげようとしています。捜査の迅速化に対する要求と冤罪を最小限に抑える圧力は、現代の刑事司法制度における法医学ゲノミクスの重要性をさらに際立たせています。これらの要因が相まって、法医学アプリケーションにおけるゲノムソリューションの需要は、米国全体で持続的かつ増加傾向にあります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場動向と展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 産業分析ツール
  • SWOT分析、要因別（政治・法律、経済技術）
  • ポーターのファイブフォース分析

第4章 米国の法医学ゲノミクス市場：製品ビジネス分析

• 製品セグメントダッシュボード
• 米国の法医学ゲノミクス市場：製品変動分析
• 米国の法医学ゲノミクス市場規模と動向分析（製品別、2021～2033年）
• アナライザとシーケンサー
• ソフトウェア
• キットと消耗品

第5章 米国の法医学ゲノミクス市場：手法ビジネス分析

• 手法セグメントダッシュボード
• 米国の法医学ゲノミクス市場：手法変動分析
• 米国の法医学ゲノミクス市場規模と動向分析（手法別、2021～2033年）
• キャピラリー電気泳動
• 次世代シーケンス
• PCR増幅
• その他

第6章 米国の法医学ゲノミクス市場：用途ビジネス分析

• 用途セグメントダッシュボード
• 米国の法医学ゲノミクス市場：用途変動分析
• 米国の法医学ゲノミクス市場規模と動向分析（用途別、2021～2033年）
• 犯罪テスト
• 父子鑑定と家族鑑定
• その他

第7章 競合情勢

• 参入企業
• 戦略マッピング
• 企業市況分析、2024年
• 参入企業概要
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Agilent Technologies
  • Promega Corporation
  • QIAGEN
  • Bio-Rad Laboratories
  • LGC Limited
  • Tri Tech Forensics
  • Verogen

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 U.S. Forensic Genomics Market, by Product, 2021 - 2033 (USD Million)
• Table 4 U.S. Forensic Genomics Market, by Method, 2021 - 2033 (USD Million)
• Table 5 U.S. Forensic Genomics Market, by Application, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 U.S. forensic genomics market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segments snapshot
• Fig. 14 Competitive landscape snapshot
• Fig. 15 U.S. forensic genomics market value, 2024 (USD million)
• Fig. 16 Market trends & outlook
• Fig. 17 PESTEL analysis
• Fig. 18 Porter's five forces analysis
• Fig. 19 U.S. Forensic Genomics Market: Product Key Takeaways
• Fig. 20 U.S. Forensic Genomics Market: Product Movement Analysis
• Fig. 21 U.S. Forensic Genomics Market, for Analyzers & Sequencers, 2021 - 2033 (USD Million)
• Fig. 22 U.S. Forensic Genomics Market, for Software, 2021 - 2033 (USD Million)
• Fig. 23 U.S. Forensic Genomics Market, for Kits & Consumables, 2021 - 2033 (USD Million)
• Fig. 24 U.S. Forensic Genomics Market: Method Key Takeaways
• Fig. 25 U.S. Forensic Genomics Market: Method Movement Analysis
• Fig. 26 U.S. Forensic Genomics Market, for Capillary Electrophoresis, 2021 - 2033 (USD Million)
• Fig. 27 U.S. Forensic Genomics Market, for Next-generation Sequencing, 2021 - 2033 (USD Million)
• Fig. 28 U.S. Forensic Genomics Market, for PCR Amplification, 2021 - 2033 (USD Million)
• Fig. 29 U.S. Forensic Genomics Market, for Others, 2021 - 2033 (USD Million)
• Fig. 30 U.S. Forensic Genomics Market: Application Key Takeaways
• Fig. 31 U.S. Forensic Genomics Market, Application Movement Analysis
• Fig. 32 U.S. Forensic Genomics Market, for Criminal Testing, 2021 - 2033 (USD Million)
• Fig. 33 U.S. Forensic Genomics Market, for Paternity & Familial Testing, 2021 - 2033 (USD Million)
• Fig. 34 U.S. Forensic Genomics Market, for Others, 2021 - 2033 (USD Million)
• Fig. 35 Strategic framework

U.S. Forensic Genomics Market Size & Trends:

The U.S. forensic genomics market size was estimated at USD 256.5 million in 2024 and is projected to reach USD 941.0 million by 2033, expanding at a CAGR of 15.65% from 2025 to 2033. This growth is driven by advancements in genomic technologies, increasing adoption of forensic DNA analysis in criminal investigations, and rising government funding for forensic research and infrastructure. Moreover, the growing need for accurate and rapid identification methods in law enforcement and legal proceedings will fuel market expansion throughout the forecast period.

Increasing Crime Rates and Complexity of Investigations

Rising incidence of criminal activity, particularly violent crimes, sexual assaults, and homicides, is one of the primary drivers of the growth in the forensic genomics market. As the volume and complexity of criminal cases increases, there is a greater need for advanced tools to provide accurate and reliable evidence. Forensic genomics enables law enforcement agencies to analyze biological samples at a highly detailed genetic level, offering superior accuracy in suspect identification and victim profiling compared to traditional forensic methods.

Moreover, the growing number of unresolved and cold cases has prompted agencies to revisit archived evidence using modern genomic techniques, leading to breakthroughs and case resolutions. The demand for rapid turnaround in investigations and pressure to minimize wrongful convictions further underscores the importance of forensic genomics in the modern criminal justice system. These factors collectively contribute to sustained and increasing demand for genomic solutions in forensic applications across the U.S.

U.S. Forensic Genomics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. forensic genomics market report based on product, method, and application:

• U.S. Forensic Genomics Product Outlook (Revenue, USD Million, 2021 - 2033)
• Analyzers & Sequencers
• Software
• Kits & Consumables
• U.S. Forensic Genomics Method Outlook (Revenue, USD Million, 2021 - 2033)
• Capillary Electrophoresis
• Next-generation Sequencing
• PCR Amplification
• Others
• U.S. Forensic Genomics Application Outlook (Revenue, USD Million, 2021 - 2033)
• Criminal Testing
• Paternity & Familial Testing
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Method Segment
  • 1.2.3. Application Segment
• 1.3. Information Analysis
  • 1.3.1. Market Formulation & Data Visualization
• 1.4. Data Validation & Publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Rising government funds and initiatives for forensic programs
    • 3.3.1.2. Increasing crime rates
    • 3.3.1.3. Technological advancements in paternity & familial testing
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. High cost of equipment
• 3.4. Industry Analysis Tools
  • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.4.2. Porter's Five Forces Analysis

Chapter 4. U.S. Forensic Genomics Market: Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. U.S. Forensic Genomics Market: Product Movement Analysis
• 4.3. U.S. Forensic Genomics Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Analyzers & Sequencers
  • 4.4.1. Analyzers & Sequencers Market, 2021 - 2033 (USD Million)
• 4.5. Software
  • 4.5.1. Software Market, 2021 - 2033 (USD Million)
• 4.6. Kits & Consumables
  • 4.6.1. Kits & Consumables Market, 2021 - 2033 (USD Million)

Chapter 5. U.S. Forensic Genomics Market: Method Business Analysis

• 5.1. Method Segment Dashboard
• 5.2. U.S. Forensic Genomics Market: Method Movement Analysis
• 5.3. U.S. Forensic Genomics Market Size & Trend Analysis, by Method, 2021 to 2033 (USD Million)
• 5.4. Capillary Electrophoresis
  • 5.4.1. Capillary Electrophoresis Market, 2021 - 2033 (USD Million)
• 5.5. Next-generation Sequencing
  • 5.5.1. Next-generation Sequencing Market, 2021 - 2033 (USD Million)
• 5.6. PCR Amplification
  • 5.6.1. PCR Amplification Market, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. U.S. Forensic Genomics Market: Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. U.S. Forensic Genomics Market: Application Movement Analysis
• 6.3. U.S. Forensic Genomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Criminal Testing
  • 6.4.1. Criminal Testing Market, 2021 - 2033 (USD Million)
• 6.5. Paternity & Familial Testing
  • 6.5.1. Paternity & Familial Testing Market, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Participant's Overview
  • 7.4.1. Illumina, Inc.
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Thermo Fisher Scientific, Inc.
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. Merck KGaA
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Agilent Technologies
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. Promega Corporation
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. QIAGEN
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Bio-Rad Laboratories
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. LGC Limited
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Tri Tech Forensics
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Verogen
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic Initiatives